{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/harnessing-power-real-world-data-drive-more-effective-decision-making-oncology-clinical#webpage",
"url": "https://www.fortrea.com/insights/harnessing-power-real-world-data-drive-more-effective-decision-making-oncology-clinical",
"name": "Harnessing the power of real-world data to drive more effective decision making in oncology clinical trials",
"description": "This Fortrea white paper explores effective decision making across oncology clinical development programs and the factors influencing oncology research strategy and clinical planning. The content focuses on oncology clinical trial decision making, oncology development strategy, clinical evidence evaluation, biomarker-informed planning, risk assessment approaches, and oncology clinical development associated with cancer research programs. The white paper highlights factors related to biomarker evaluation, safety and efficacy interpretation, operational planning, portfolio prioritization, and clinical evidence assessment affecting oncology development decisions. Fortrea discusses scientific and operational perspectives designed to support strategic oncology decision making, strengthen clinical development planning, and improve execution approaches across oncology clinical programs. By integrating clinical evidence evaluation with biomarker-informed planning and oncology development strategies, the white paper provides insights into oncology clinical trial decision making across evolving oncology research and clinical development environments."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Harnessing the power of real-world data to drive more effective decision making in oncology clinical trials",
"item": "https://www.fortrea.com/insights/harnessing-power-real-world-data-drive-more-effective-decision-making-oncology-clinical"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/harnessing-power-real-world-data-drive-more-effective-decision-making-oncology-clinical#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/harnessing-power-real-world-data-drive-more-effective-decision-making-oncology-clinical#webpage"
},
"headline": "Effective Decision Making Across Oncology Clinical Development Programs | Fortrea White Paper",
"description": "This Fortrea white paper explores effective decision making across oncology clinical development programs and the factors influencing oncology research strategy and clinical planning. The content focuses on oncology clinical trial decision making, oncology development strategy, clinical evidence evaluation, biomarker-informed planning, risk assessment approaches, and oncology clinical development associated with cancer research programs. The white paper highlights factors related to biomarker evaluation, safety and efficacy interpretation, operational planning, portfolio prioritization, and clinical evidence assessment affecting oncology development decisions. Fortrea discusses scientific and operational perspectives designed to support strategic oncology decision making, strengthen clinical development planning, and improve execution approaches across oncology clinical programs. By integrating clinical evidence evaluation with biomarker-informed planning and oncology development strategies, the white paper provides insights into oncology clinical trial decision making across evolving oncology research and clinical development environments.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-03/effective-decision-making-in-oncology-clinical%20trials.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-21",
"dateModified": "2025-03-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-03/effective-decision-making-in-oncology-clinical%20trials.pdf",
"encodingFormat": "application/pdf"
}
}
]
}